ChemBioChem
10.1002/cbic.201700154
FULL PAPER
FmocLys(Boc) (3-azidopropyl)amide 11: To
a
solution of Fmoc-
3
CD OD) δ ppm: 7.91-7.77 (d, J = 8.8 Hz, 2H, Ar), 7.23-7.07 (d, J = 8.8 Hz,
Lys(Boc)-OH (1.0 g, 2.13 mmol) in CH
5.5 mmol) followed by 1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide
EDC (1.2 g, 6.3 mmol) and HOBt (850 mg, 6.29 mmol) were added. The
mixture was stirred at room temperature for 2 days. CH Cl was added
and the organic layer was washed with a 1M HCl (10 mL), a white
precipitate was formed and removed by filtration. The organic layer was
2
Cl
2
(20 mL), 3-azidopropylamine
2H, Ar), 4.95 (d, J = 7.7 Hz, 1H, H1), 4.46 (dd, J = 8.8, 5.7 Hz, 1H, CH
Lys), 3.92 (d, J = 3.4 Hz, 1H, H4), 3.85-3.69 (m, 4H, H2, H5, H6), 3.60
(
(dd, J = 9.7, 3.4 Hz, 1H, H3), 3.36 (t, J = 6.7 Hz, 2H, CH
(m, 2H, CH EtN ), 3.04 (t, J = 6.7 Hz, 2H, CH ), 1.90-1.74 (m, 4H, CH
CH CH ), 1.38-1.56 (m, 4H, CH , CH ), 1.41 (s, 9H, 3 x CH
NMR (100 MHz, CD OD) δ ppm: 174.8, 169.8, 162.0, 130.3, 128.8, 117.3,
2 3
N ), 3.30-3.27
2
2
2
3
2
2
,
C
13
2
N
2 3
2
2
3
).
3
washed with water, dried (Na
residue was purified by silica gel flash chromatography (CH
5:5) to afford compound 11 (753 mg, 58%) as an amorphous white solid.
= 0.33 (CH Cl ) δ ppm: 7.73
/MeOH 95:5). 1H NMR (400 MHz, CDCl
d, J = 7.5 Hz, 2H, CHAr), 7.55 (d, J = 7.4 Hz, 2H, CHAr), 7.37 (t, J = 7.5
Hz, 2H, CHAr), 7.27 (t, J = 7.4 Hz, 2H, CHAr), 6.83 (bs, 1H, NH amide),
2
SO
4
) and evaporated under vacuum. The
102.4, 77.1, 74.8, 72.2, 70.2, 62.4, 55.6, 50.1, 41.0, 37.8, 32.8, 30.6,
2
Cl /MeOH
2
29.7, 28.8, 24.4. HR-ESI-QToF MS (positive mode): m/z calcd. for
+
9
R
(
C
27
H
43
N
6
O
10 [M+H] 611.3041, found 611.3045.
f
2
2
3
4
7
-(β-D-Galactopyranosyloxy)-benzamide Lys (3-azidopropyl) amide
h: Compound 14 (636 mg, 1 mmol) was solubilized in HCl 1N (10 mL).
5
4
4
CH
(
.86 (bd, J = 5.6 Hz, 1H, NH urethane), 4.78 (s, 1H, NH urethane), 4.46-
The mixture was stirred at 70°C for 5 min under microwave irradiation.
Polyvinyl pyridine (PVP 2% cross-linked, 60 mesh, 8 meq/g) was added
to neutralize the reaction. The mixture was filtered and the PVP washed
.24 (m, 2H, CH
H, CH CH CH
CH
100 MHz, CDCl
2
Fmoc), 4.16 (m, 2H, CHLys/CHFmoc), 3.37 – 3.19 (m,
), 3.08 (m, 2H, CH ), 1.77-1.68 (m, 4H, CH
, CH
) δ ppm: 172.2, 156.6, 156.3, 127. 8, 127.1, 125.2,
20.0, 79.2, 67.1, 54.9, 49.1, 47.1, 39.9, 37.0, 32.1, 29.6, 28.7, 28.5,
2
2
2
N
3
2
2
,
13
2
2
N
3
), 1.55-1.27 (m, 4H, CH
2
2 3
, 1.42 (s, 9H, 3CH ). C NMR
with MeOH. The solvent was evaporated under vacuum to afford
3
compound 8 (518 mg, 97%) as an amorphous white solid. [α]
20
= -2.0 (c
D
1
2
1
=
7
1
2
1.0 H O). H NMR (400 MHz, D
2
O) δ ppm: 7.89-7.79 (m, 2H, Ar), 7.28-
.18 (m, 2H, Ar), 5.17 (d, J = 7.5 Hz, 1H, H1), 4.42 (dd, J = 8.7, 6.0 Hz,
H, CH Lys), 4.02 (dd, J = 3.2, 0.8 Hz, 1H, H4), 3.97-3.74 (m, 5H, H2,
2.6. HR-ESI-QToF MS (positive mode): m/z calcd. for C29
H N O
39 6 5
+
[M+H] 551.2982, found 551.2985.
H3, H5, H6), 3.37 (t, J = 6.6 Hz, 2H, CH
NHCH EtN ), 3.01 (t, J = 7.7 Hz, 2H, CH ), 1.98-1.65 (m, 6H, CH
CH CH , CH ). C NMR (100 MHz, D O) δ ppm:
174.2, 170.2, 159.7, 129.4, 127.3, 116.2, 115.4, 100.1, 75.5, 72.5, 70.4,
68.4, 60.7, 54.6, 48.7, 39.2, 36.7, 30.4, 27.6, 26.3, 22.3. HR-ESI-QToF
[M+H]+ 511.2516, found
35 6 8
MS (positive mode): m/z calcd. for C23H N O
2 3
N ), 3.35-3.28 (m, 2H,
Lys(Boc) (3-azidopropyl) amide 12: A solution of FmocLys(Boc) (3-
azidopropyl) amide 11 (639 mg, 1.16 mmol) in piperidine/THF (4:6, v/v)
was stirred at rt for 4 h. The solvent was coevaporated with toluene (7
2
3
2
2
,
13
2
2
N
3
2
), 1.50 (m, 2H, CH
2
2
times) and CHCl
3
(3 times) to obtain a yellow oil purified by silica gel
Cl /MeOH 9:1) to afford Lys(Boc) (3-
flash chromatography (CH
2
2
azidopropyl) amide (358 mg, 92%) as
a
clear oil.
) δ ppm: 7.51 (d, J = 4.3
CH CH , CH
), 1.90-1.64 (m, 5H, CH, CH , CH CH ),
). C NMR (100 MHz, CDCl ) δ
ppm: 175.1, 156.1, 79.2, 55.0, 49.3, 40.1, 36.6, 34.5, 29.9, 28.9, 28.4,
R
f
=
0.43
511.2522.
1
2
(CH Cl
2
/MeOH 9:1). H NMR (400 MHz, CDCl
3
Hz, 1H, NH), 4.59 (s, 1H, NH), 3.41-3.22 (m, 5H, CH
lys), 3.18-3.02 (m, 2H, CH
.59-1.28 (m, 12H, CH-7’-CH, 3 x CH
2
2
2 3
N
2-Methyl-2-[(prop-2-ynoxy)methyl]propane-1,3-diol
16.
Sodium
2
2
2
2 3
N
hydride (400 mg, 10 mmol) was added to
a
solution of 1,1,1-
13
1
3
3
tris(hydroxymethyl)ethane (1.2 g, 10 mmol) in dry THF (30 mL) under
argon atmosphere. Then, a solution of propargyl bromide (0.52 mL, 5
mmol) in dry THF (10 mL) was added dropwise at 0°C. The mixture was
stirred overnight and water was added to quench the reaction. After 15
min, the crude mixture was coevaporated with toluene, and directly
purified by silica flash chromatography (EtOAc 50% to 100% in
2
2.9. HR-ESI-QToF MS (positive mode): m/z calcd. for C14
H N O
29 6 3
+
[M+H] 329.2301, found 329.2300.
4
-(2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyloxy)-benzamide
Lys(Boc) (3-azidopropyl) amide 13: Lys(Boc) (3-azidopropyl)amide 4
337 mg, mmol) and 4-(2,3,4,6-tetra-O-acetyl-β-D-
galactopyranosyloxy)-benzoic acid 5 (472 mg, 1 mmol) were solubilised
in CH Cl (4.5 mL). The solution was stirred with molecular sieve 4Ǻ for
0 min. BOP (505.6 mg, 1 mmol) and DIEA (340 µL, 2 mmol) were
1
cyclohexane) leading to compound 16 (480 mg, 61%). H NMR (400 Mz,
(
1
CDCl
3
) 4.16 (d, J = 2.4 Hz, 2H, CH
2
C≡CH), 3.62-3.54 (m, 6H, CH
2
), 2.45
(t, J = 2.4 Hz, 1H, ≡CH), 0.85 (s, 3H, CH
3
). In agreement with the
2
2
3
added and the mixture was stirred at rt for 1 h. The solvent was
evaporated under vacuum and the residue was purified by silica gel flash
chromatography (cyclohexane/EtOAc) to afford compound 13 (820 mg,
Immobilization of alkynes 16 and 18 on azido-functionalized solid
support 17 by CuAAC: An aqueous solution of propargyl diethylene
glycol 18 or compound 16 (0.2 M, 50 µL, 10 mol), freshly prepared
f 2 2
= 0.41 (CH Cl H
/MeOH 95:5). 1
9
9%) as an amorphous white solid. R
NMR (400 MHz, CDCl ) δ ppm: 7.79 (d, J = 8.7 Hz, 2H, Ar), 7.06-6.99 (d,
J = 8.7 Hz 2H, Ar), 6.90 (bs, 1H, NHCO), 5.55-5.43 (m, 2H, H2, H4),
.22-5.04 (m, 2H, H1, H3), 4.59 (m, 1H, CH Lys), 4.23-4.09 (m, 3H, H5,
H6), 3.39-3.29 (m, 4H, CH CH CH ), 3.11 (m, 2H, CH ), 2.18 (s, 3H,
CO), 2.06 (s, 3H, CH CO), 2.06 (s, 3H, CH CO), 2.01 (s, 3H,
CO), 1.99-1.88 (m, 1H, CH), 1.84-1.74 (m, 3H, CH CH , CH),
), 1.47-1.35 (m, 11H, CH , 3xCH
). 1 C NMR
) δ ppm: 171.0, 169.3, 169.2, 169.1, 158.5, 128.0, 127.3,
aqueous solutions of CuSO (0.04 M, 25 µL, 1 mol) and sodium
4
3
ascorbate (0.1 M, 50 µL, 5 mol), TEAAc buffer (2 M, 25 µL), tris(3-
hydroxypropyltriazolylmethyl)amine (THPTA, 0.1 M, 20 µL, 2 mol) and
MeOH (80 µL) were added to 1 µmol of azide solid support 17. The
resulting mixture was heated at 65°C under microwave for 30 min at 250
5
2
2
2
N
3
2
CH
CH
3
3
3
3
rpm. The solution was removed and CPG beads were washed with H
2
O
2
2 3
N
3
(
5 mL), MeOH (5 mL) and CH Cl (5 mL) then dried affording 19 and 20.
2
2
1.59-1.48 (m, 2H, CH
2
2
3
(100 MHz, CDCl
3
Glyco-oligonucleotide synthesis: The oligonucleotide synthesis on
solid support was performed on a DNA synthesizer Applied Biosystems
1
16.0, 98.0, 76.2, 70.2, 70.0, 67.5, 65.8, 60.4, 52.5, 48.1, 39.0, 36.1,
1.0 , 28.5, 27.6, 27.4 , 21.7, 19.7, 19.6, 19.5. HR-ESI-QToF MS
3
(381A or 394 DNA synthesizer). Reactions under microwave activation
50 6
positive mode): m/z calcd. for C35H N O
14Na [M+Na]+ 801.3283, found
(
were performed on an Anton Paar Monowave 300 system. Solutions of
Cap A, Cap B and iodide were purchased from Link Technologies as well
801.3286.
3
as the commercial solid supports. Solutions of TCA and CH CN for DNA
4
-(β-D-Galactopyranosyloxy)-benzamide Lys(Boc) (3-azidopropyl)
synthesis were purchased from Biosolve. Cy3-amidite was purchased
from GE Healthcare. All glycooligonucleotides were purified and
analyzed by C18 reversed-phase HPLC (Macherey-Nagel, Nucleodur
amide 14: Compound 6 was solubilized in MeOH/H
v/v/v) and the mixture was stirred at rt for 2.5 h. The solvent was
2
O/NEt (8 mL, 5:1:2,
3
evaporated to afford compound 14 (695 mg, quantitative) as an
4
.6×75 mm, 3 mM) on a Dionex Ultimate 3000 system with a Reodyn
1
amorphous white solid. R
f
2
= 0.13 (CH Cl
2
/MeOH 9:1). H NMR (400 MHz,
injector and a detector UV DAD 3000. Oligonucleotides were dosed by
This article is protected by copyright. All rights reserved.